Ypsomed Holding AG
🇨🇭XSWX.YPSNSwitzerlandNot reported
PriceCHF 360.40-1.40 (-0.39%)
Latest anomalies
Negative 1 detected in the last 120 days
- High: 10
- Medium: 2
- Low: 0
Volume: a spike above the 20-day average
Cash conversion cycle: a sudden drop below its trailing quarter average
Days sales outstanding: a sudden drop below its trailing quarter average
Financial leverage: a sudden drop below its trailing quarter average
Fixed asset turnover: a sudden spike above its trailing quarter average
Free with a Finzer account.
Profile
- Switzerland
Identity
- Exchange
- SIX Swiss Exchange . XSWX
- Type
- Stock
- ISIN
- CH0019396990
- CUSIP
- Not reported
Company
- Employees
- 2,000
- Headquarters
- Burgdorf, United Kingdom
- Website
- https://www.ypsomed.com
Market
- Shares outstanding
- 13.6M
- Market cap
- CHF 4.92B
Highlights
- Market cap
- CHF 4.92B
- EPS LTM
- CHF 6.41
- P/E LTM
- 52.89
- Div yield
- 0.59%
Fundamentals (LTM)
- Revenue
- CHF 748.87M-8.97%down year on year
- Net income
- CHF 87.5M-25.56%down year on year
- Gross margin
- 39%+7.37%up year on year
- Free cash flow
- -CHF 57.4M-288.59%down year on year
Latest news
News is not sourced for this exchange.
Business summary
Ypsomed Holding AG is listed on SIX Swiss Exchange (Switzerland) under the ticker YPSN. Its market capitalisation is CHF 4.92B, from 13.6M shares outstanding, as of . Across the 249 trading sessions to the shares traded between CHF 260.50 and CHF 418.00, and the last close of CHF 360.40 sits 63% of the way up that range. The company is headquartered in Burgdorf, United Kingdom, and employs about 2,000 people. The same company also trades as OWX on Frankfurt Stock Exchange, and as 0QLQ on London Stock Exchange.
Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for safe and simple self-medication companies. The company operates through three segments: Ypsomed Delivery Systems, Ypsomed Diabetes Care, and Others. The Ypsomed Delivery Systems segment provides various injection systems, such as pen injectors, auto-injectors, and wearable injectors, as well as other smart devices. This segment offers its products under the YDS brand. The Ypsomed Diabetes Care segment sells and trades in insulin pumps, infusion sets, pen needles, blood glucose monitoring systems, accessories, and other day-to-day items for diabetics. This segment offers its products under the mylife brand name. The company offers precision turned parts; and contract manufacturing and other services. It markets its products through pharmaceutical partners, as well as through its own distribution network and independent distributors. It operates in Switzerland, Europe, North America, and internationally. Ypsomed Holding AG was founded in 1984 and is headquartered in Burgdorf, Switzerland.